Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aplastic anemia

R Storb1

  • 1Transplantation Biology Program, Fred Hutchinson Cancer Research Center, University of Washington School of Medicine, Seattle, USA.

Journal of Intravenous Nursing : the Official Publication of the Intravenous Nurses Society
|January 10, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1992
Same author

Pharmacologic, toxicologic, and marrow transplantation studies in dogs given succinyl acetone.

Transplantation·1992
Same author

Treatment of acute graft-versus-host disease with a nonmitogenic anti-CD3 monoclonal antibody.

Transplantation·1992
Same author

Succinyl acetone plus methotrexate as graft-versus-host disease prophylaxis in DLA-haploidentical canine littermate marrow grafts.

Transplantation·1992
Same author

Specific growth inhibition of primitive hematopoietic progenitor cells mediated through monoclonal antibody binding to major histocompatibility class II molecules.

Blood·1992
Same author

Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate.

Blood·1992
Same journal

The role of the perfusionist.

Journal of intravenous nursing : the official publication of the Intravenous Nurses Society·2002
Same journal

Silicone catheter fracture secondary to stress events and a dressing technique to reduce those events.

Journal of intravenous nursing : the official publication of the Intravenous Nurses Society·2002
Same journal

Fluid resuscitation in acutely injured patients.

Journal of intravenous nursing : the official publication of the Intravenous Nurses Society·2002
Same journal

A story on childhood immunization practices, complete with camera footage of a nurse administering "a shot" to a child without using personal protective equipment.

Journal of intravenous nursing : the official publication of the Intravenous Nurses Society·2002
Same journal

Clinical application of the World Health Organization analgesic ladder.

Journal of intravenous nursing : the official publication of the Intravenous Nurses Society·2002
Same journal

Laboratory sampling. Alternate site perspectives.

Journal of intravenous nursing : the official publication of the Intravenous Nurses Society·2002
See all related articles

Aplastic anemia, a rare blood disorder, has low survival rates with supportive care. Hematopoietic stem cell transplantation offers the best long-term survival outcomes for patients.

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • Aplastic anemia is characterized by hypocellular bone marrow and pancytopenia.
  • Incidence varies globally, with higher rates in East Asia.
  • Etiologies include intrinsic stem cell defects, immune dysregulation, infections, toxins, and hereditary factors.

Purpose of the Study:

  • To review the pathogenesis, current therapies, and outcomes for aplastic anemia.
  • To compare the efficacy of supportive care, immunosuppressive therapy, and hematopoietic stem cell transplantation.

Main Methods:

  • Literature review of aplastic anemia pathogenesis and treatment modalities.
  • Analysis of survival data for different treatment approaches.

Main Results:

Related Experiment Videos

  • Supportive care yields poor survival (approx. 20% at 1 year).
  • Immunosuppressive therapy shows variable response rates (20-80%) but carries risks of relapse and clonal evolution.
  • Allogeneic hematopoietic stem cell transplantation achieves high long-term event-free survival (approx. 90%).

Conclusions:

  • Hematopoietic stem cell transplantation is the most effective treatment for aplastic anemia.
  • Immunosuppressive therapy remains an option but with guarded long-term prognosis.
  • Further research into pathogenesis and novel therapies is warranted.